Molecular mechanisms mediated by Human Endogenous Retroviruses (HERVs) in autoimmunity

Reviews in Medical Virology

Volumn 19, Issue 5, 2009, Pages 273-286

  Balada, Eva ^a   Ordi Ros, Josep ^a   Vilardell Tarrés, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HUMAN ENDOGENOUS RETROVIRUS PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MITOGENIC AGENT; NUCLEOPROTEIN; RETINOIC ACID; SM ANTIBODY; STEROID HORMONE; SUPERANTIGEN; TAX PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VITAMIN;

ANTIGEN RECOGNITION; AUTOIMMUNITY; CONNECTIVE TISSUE DISEASE; CROSS REACTION; CYTOTOXICITY; DNA METHYLATION; DORMANCY; ENDOGENOUS RETROVIRUS; ENVIRONMENTAL FACTOR; GENE EXPRESSION REGULATION; GENE INSERTION SEQUENCE; GENE SEQUENCE; GENOTOXICITY; HUMAN; HUMAN ENDOGENOUS RETROVIRUS; HYPOXIA; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MICROORGANISM; MOLECULAR BIOLOGY; MOLECULAR MIMICRY; NONHUMAN; PROTEIN EXPRESSION; RETROPOSON; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; TRANSPOSON; ULTRAVIOLET RADIATION; VIRUS EXPRESSION; AUTOIMMUNE DISEASE; GENETIC EPIGENESIS; GENETICS; HUMAN GENOME; IMMUNOLOGY; METABOLISM; VIROLOGY; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME;

AUTOIMMUNE DISEASES; CROSS REACTIONS; ENDOGENOUS RETROVIRUSES; EPIGENESIS, GENETIC; GENOME, HUMAN; GENOME, VIRAL; HUMANS; RETROELEMENTS; RETROVIRIDAE PROTEINS; SUPERANTIGENS; VIRUS INTEGRATION;

EID: 70350704831     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.622     Document Type: Review

References (102)

1. van de Lagemaat LN, Landry JR, Mager DL, Medstrand P. Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions. Trends Genet 2003; 19: 530-536. (Pubitemid 37204911)
2. Deininger PL, Batzer MA. Mammalian retroelements. Genome Res 2002; 12: 1455-1465.
3. Jurka J. Repbase update: a database and an electronic journal of repetitive elements. Trends Genet 2000; 16: 418-420.
4. Voisset C, Weiss RA, Griffiths DJ. Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev 2008; 72: 157-196, table of contents.
5. Moyes D, Griffiths DJ, Venables PJ. Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease. Trends Genet 2007; 23: 326-333. (Pubitemid 46978355)
6. Marguerat S, Wang WY, Todd JA, Conrad B. Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes. Diabetes 2004; 53: 852-854. (Pubitemid 38270659)
7. Magistrelli C, Samoilova E, Agarwal RK, et al. Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics 1999; 49: 829-834. (Pubitemid 29381443)
8. Pullmann R Jr., Bonilla E, Phillips PE, Middleton FA, Perl A. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis Rheum 2008; 58: 532-540. (Pubitemid 351294887)
9. Mack M, Bender K, Schneider PM. Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 2004; 56: 321-332.
10. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 2001; 11: 1531-1535. (Pubitemid 32931016)
11. Moyes DL, Martin A, Sawcer S, et al. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 2005; 86: 337-341. (Pubitemid 41096703)
12. Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, Tristem M. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERVK( HML2): implications for present-day activity. J Virol 2005; 79: 12507-12514. (Pubitemid 41346113)
13. Hughes JF, Coffin JM. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc Natl Acad Sci USA 2004; 101: 1668-1672.
14. Macfarlane C, Simmonds P. Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. J Mol Evol 2004; 59: 642-656. (Pubitemid 40110104)
15. Nelson PN, Lever AM, Bruckner FE, Isenberg DA, Kessaris N, Hay FC. Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigens. Ann Rheum Dis 1994; 53: 749-754. (Pubitemid 24347503)
16. Nelson PN, Lever AM, Smith S, et al. Molecular investigations implicate human endogenous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic disease. Immunol Invest 1999; 28: 277-289. (Pubitemid 29372699)
17. di Giovine FS, Bailly S, Bootman J, Almond N, Duff GW. Absence of lentiviral and human T cell leukemia viral sequences in patients with rheumatoid arthritis. Arthritis Rheum 1994; 37: 349-358. (Pubitemid 24093626)
18. Herrmann M, Neidhart M, Gay S, Hagenhofer M, Kalden JR. Retrovirus-associated rheumatic syndromes. Curr Opin Rheumatol 1998; 10: 347-354.
19. Boller K, Schonfeld K, Lischer S, et al. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol 2008; 89: 567-572. (Pubitemid 351622454)
20. Rasmussen HB, Kelly MA, Francis DA, Clausen J. Association between the endogenous retrovirus HRES-1 and multiple sclerosis in the United Kingdom - evidence of genetically different disease subsets? Dis Markers 2000; 16: 101-104.
21. Banki K, Maceda J, Hurley E, et al. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci USA 1992; 89: 1939-1943.
22. Query CC, Keene JD. A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 1987; 51: 211-220.
23. Mason AL, Xu L, Guo L, Garry RF. Retroviruses in autoimmune liver disease: genetic or environmental agents? Arch Immunol Ther Exp (Warsz) 1999; 47: 289-297.
24. Talal N, Flescher E, Dang H. Evidence for possible retroviral involvement in autoimmune diseases. Ann Allergy 1992; 69: 221-224.
25. Talal N, Flescher E, Dang H. Are endogenous retroviruses involved in human autoimmune disease? J Autoimmun 1992; 5(Suppl A): 61-66.
26. Li JM, Fan WS, Horsfall AC, et al. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin Exp Immunol 1996; 104: 388-393.
27. Chu JL, Drappa J, Parnassa A, Elkon KB. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 1993; 178: 723-730. (Pubitemid 23218222)
28. Wu J, Zhou T, He J, Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993; 178: 461-468. (Pubitemid 23218194)
29. Andersson G, Svensson AC, Setterblad N, Rask L. Retroelements in the human MHC class II region. Trends Genet 1998; 14: 109-114. (Pubitemid 28153329)
30. Kulski JK, Gaudieri S, Inoko H, Dawkins RL. Comparison between two human endogenous retrovirus (HERV)-rich regions within the major histocompatibility complex. J Mol Evol 1999; 48: 675-683. (Pubitemid 29287957)
31. Kulski JK, Dawkins RL. The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics 1999; 49: 404-412.
32. Dangel AW, Mendoza AR, Baker BJ, et al. The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes speciesspecific genomic patterns among Old World primates. Immunogenetics 1994; 40: 425-436.
33. Zhu ZB, Hsieh SL, Bentley DR, Campbell RD, Volanakis JE. A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J Exp Med 1992; 175: 1783-1787.
34. Helms C, Pelsue S, Cao L, et al. The tetratricopeptide repeat domain 7 gene is mutated in flaky skin mice: a model for psoriasis, autoimmunity, and anemia. Exp Biol Med (Maywood) 2005; 230: 659-667. (Pubitemid 41506861)
35. Lower R, Tonjes RR, Korbmacher C, Kurth R, Lower J. Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol 1995; 69: 141-149. (Pubitemid 24378787)
36. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921. (Pubitemid 32165345)
37. Waterston RH, Lindblad-Toh K, Birhey E, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420: 520-562. (Pubitemid 35477048)
38. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997; 90: 303-313. (Pubitemid 27329715)
39. Muraro PA, Jacobsen M, Necker A, et al. Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. J Immunol Methods 2000; 246: 131-143. (Pubitemid 30838508)
40. van den Beemd R, Boor PP, van Lochem EG, et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000; 40: 336-345.
41. Meylan F, De Smedt M, Leclercq G, et al. Negative thymocyte selection to HERV-K18 superantigens in humans. Blood 2005; 105: 4377-4382. (Pubitemid 40720784)
42. SutkowskiN, Conrad B, Thorley-LawsonDA,Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001; 15: 579-589.
43. Luppi P, Zanone MM, Hyoty H, et al. Restricted TCR V beta gene expression and enterovirus infection in type I diabetes: a pilot study. Diabetologia 2000; 43: 1484-1497. (Pubitemid 32734854)
44. Murphy VJ, Harrison LC, Rudert WA, et al. Retroviral superantigens and type 1 diabetes mellitus. Cell 1998; 95: 9-11; discussion 16.
45. Lan MS, Mason A, Coutant R, et al. HERV-K10s and immune-mediated (type 1) diabetes. Cell 1998; 95: 14-16; discussion 16.
46. Lower R, Tonjes RR, Boller K, et al. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 1998; 95: 11-14; discussion 16. (Pubitemid 28458018)
47. Lapatschek M, Durr S, Lower R, Magin C, Wagner H, Miethke T. Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK(1,2)22 encoding superantigen activity. J Virol 2000; 74: 6386-6393.
48. Mein CA, Esposito L, Dunn MG, et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998; 19: 297-300. (Pubitemid 28309348)
49. Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen. J Exp Med 1996; 184: 971-980.
50. Stauffer Y, Marguerat S, Meylan F, et al. Interferonalpha- induced endogenous superantigen. A model linking environment and autoimmunity. Immunity 2001; 15: 591-601.
51. Perron H, Jouvin-Marche E, Michel M, et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 2001; 287: 321-332. (Pubitemid 32804018)
52. Oostendorp RA, Schaaper WM, Post J, Von Blomberg BM, Meloen RH, Scheper RJ. Suppression of lymphocyte proliferation by a retroviral p15E-derived hexapeptide. Eur J Immunol 1992; 22: 1505-1511.
53. Haraguchi S, Liu WT, Cianciolo GJ, Good RA, Day NK. Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes. Cell Immunol 1992; 141: 388-397.
54. Haraguchi S, Good RA, James-Yarish M, Cianciolo GJ, Day NK. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc Natl Acad Sci USA 1995; 92: 3611-3615.
55. Nelson M, Nelson DS, Cianciolo GJ, Snyderman R. Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products. Cancer Immunol Immunother 1989; 30: 113-118. (Pubitemid 20000877)
56. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985; 230: 453-455. (Pubitemid 16192559)
57. Scheeren RA, Oostendorp RA, van der Baan S, Keehnen RM, Scheper RJ, Meijer CJ. Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response. Clin Exp Immunol 1992; 89: 94-99.
58. Naito T, Ogasawara H, Kaneko H, et al. Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus. J Clin Immunol 2003; 23: 371-376. (Pubitemid 37083191)
59. Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H, Marche PN. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol 2006; 176: 7636-7644. (Pubitemid 43849064)
60. Kelleher CA, Wilkinson DA, Freeman JD, Mager DL, Gelfand EW. Expression of novel-transposon-containing mRNAs in human T cells. J Gen Virol 1996; 77(Pt 5): 1101-1110. (Pubitemid 26142346)
61. Krieg AM, Gourley MF, Klinman DM, Perl A, Steinberg AD. Heterogeneous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1992; 8: 1991-1998. (Pubitemid 23054099)
62. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001; 50: 434-442. (Pubitemid 32938886)
63. Sibata M, Ikeda H, Katumata K, Takeuchi K, Wakisaka A, Yoshoki T. Human endogenous retroviruses: expression in various organs in vivo and its regulation in vitro. Leukemia 1997; 11(Suppl 3): 145-146. (Pubitemid 27313466)
64. Katsumata K, Ikeda H, Sato M, et al. Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin Immunol 1999; 93: 75-80. (Pubitemid 29459964)
65. Serra C, Mameli G, Arru G, Sotgiu S, Rosati G, Dolei A. In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis. J Neurovirol 2003; 9: 637-643.
66. Kwun HJ, Han HJ, Lee WJ, Kim HS, Jang KL. Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex virus type 1 immediate early protein 0. Virus Res 2002; 86: 93-100.
67. Lee WJ, Kwun HJ, Kim HS, Jang KL. Activation of the human endogenous retrovirusWlong terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells 2003; 15: 75-80.
68. Brudek T, Luhdorf P, Christensen T, Hansen HJ, Moller-Larsen A. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV. J Neuroimmunol 2007; 187: 147-155. (Pubitemid 47001539)
69. Brudek T, Christensen T, Hansen HJ, Bobecka J, Moller-Larsen A. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res Hum Retroviruses 2004; 20: 415-423. (Pubitemid 38582271)
70. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y. Detection of HERVK(HML-2) viral RNA in plasma of HIV type 1- infected individuals. AIDS Res Hum Retroviruses 2006; 22: 979-984. (Pubitemid 46100682)
71. Contreras-Galindo R, Lopez P, Velez R, Yamamura Y. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses 2007; 23: 116-122. (Pubitemid 46214180)
72. Laderoute MP, Giulivi A, Larocque L, et al. The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia. Aids 2007; 21: 2417-2424. (Pubitemid 350145173)
73. Garrison KE, Jones RB, Meiklejohn DA, et al. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007; 3: e165.
74. Frank O, Jones-Brando L, Leib-Mosch C, Yolken R, Seifarth W. Altered transcriptional activity of human endogenous retroviruses in neuroepithelial cells after infection with Toxoplasma gondii. J Infect Dis 2006; 194: 1447-1449. (Pubitemid 44706514)
75. Buetti E, Kuhnel B, Diggelmann H. Dual function of a nuclear factor I binding site in MMTV transcription regulation. Nucleic Acids Res 1989; 17: 3065-3078. (Pubitemid 19122224)
76. Gowland PL, Buetti E. Mutations in the hormone regulatory element of mouse mammary tumor virus differentially affect the response to progestins, androgens, and glucocorticoids. Mol Cell Biol 1989; 9: 3999-4008. (Pubitemid 19216291)
77. Cato AC, Miksicek R, Schutz G, Arnemann J, Beato M. The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. Embo J 1986; 5: 2237-2240.
78. Vogetseder W, Feng J, Haibach C, Mayerl W, Dierich MP. Detection of a 67-kD glycoprotein in human tumor cell lines by a monoclonal antibody established against a recombinant human endogenous retrovirus-K envelope-gene-encoded protein. Exp Clin Immunogenet 1995; 12: 96-102.
79. Wilkinson DA, Mager DL, Leong JAC. Endogenous human retroviruses. In The Retroviridae, Levy JAP (ed.). Plenum Press: New York, 1994; 465-535.
80. Ogasawara H, Naito T, Kaneko H, et al. Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 533-538. (Pubitemid 32202655)
81. Tovar Sepulveda VA, Berdel B, Coffin JM, Reuss FU. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment. Virology 2000; 275: 98-106. (Pubitemid 30729047)
82. Ogasawara H, Okada M, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H. Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. Clin Exp Rheumatol 2003; 21: 733-738. (Pubitemid 38008756)
83. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988; 140: 2197-2200. (Pubitemid 18098475)
84. Richardson BC, Strahler JR, Pivirotto TS, et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 1992; 35: 647-662.
85. Takeuchi T, Amano K, Sekine H, Koide J, Abe T. Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. J Clin Invest 1993; 92: 3008-3016. (Pubitemid 24006572)
86. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990; 33: 1665-1673.
87. Mizugaki M, Yamaguchi T, Ishiwata S, Shindo H, Hishinuma T, Nozaki S, Nose M. Alteration of DNA methylation levels in MRL lupus mice. Clin Exp Immunol 1997; 110: 265-269. (Pubitemid 27469600)
88. Quddus J, Johnson KJ, Gavalchin J, et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993; 92: 38-53. (Pubitemid 23208979)
89. Khan AS, Muller J, Sears JF. Early detection of endogenous retroviruses in chemically induced mouse cells. Virus Res 2001; 79: 39-45. (Pubitemid 32817154)
90. Lowy DR, Rowe WP, Teich N, Hartley JW. Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine. Science 1971; 174: 155-156.
91. Hsieh LL, Weinstein IB. Factors influencing the expression of endogenous retrovirus-like sequences in Rat 6 cells. Mol Carcinog 1990; 3: 344-349.
92. Larsson E, Venables PJ, Andersson AC, et al. Expression of the endogenous retrovirus ERV3 (HERV-R) during induced monocytic differentiation in the U-937 cell line. Int J Cancer 1996; 67: 451-456. (Pubitemid 26274141)
93. Kannan P, Buettner R, Pratt DR, Tainsky MA. Identification of a retinoic acid-inducible endogenous retroviral transcript in the human teratocarcinoma- derived cell line PA-1. J Virol 1991; 65: 6343-6348.
94. Hohenadl C, Germaier H, Walchner M, et al. Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J Invest Dermatol 1999; 113: 587-594. (Pubitemid 29489621)
95. Bessis D, Moles JP, Basset-Seguin N, Tesniere A, Arpin C, Guilhou JJ. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin. Br J Dermatol 2004; 151: 737-745. (Pubitemid 39482106)
96. Weiss RA, Payne LN. The heritable nature of the factor in chicken cells which acts as a helper virus for Rous sarcoma virus. Virology 1971; 45: 508-515.
97. Weiss RA, Friis RR, Katz E, Vogt PK. Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. Virology 1971; 46: 920-938.
98. Niwa O, Sugahara T. Radiation induction of endogenous type C virus from mouse cells transformed in vitro by murine sarcoma virus. J Natl Cancer Inst 1979; 62: 329-335. (Pubitemid 9094723)
99. Mi S, Lee X, Li X, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000; 403: 785-789. (Pubitemid 30111841)
100. Blond JL, Lavillette D, Cheynet V, et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 2000; 74: 3321-3329. (Pubitemid 30143757)
101. Lee X, Keith JC, Jr., Stumm N, et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 2001; 22: 808-812. (Pubitemid 33150398)
102. Knerr I, Beinder E, Rascher W. Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J Obstet Gynecol 2002; 186: 210-213. (Pubitemid 34165435)